Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Background The global surge in ultra-processed food (UPF) consumption is a major public health challenge, particularly among ...
World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...
Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Disc. 23, 656–657; 2024). With the ...
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) stock is skyrocketing on Wednesday, with a session volume of 2.73 million compared to the average volume of 389.09 thousand, as per data from Benzinga Pro ...
The future of cancer drug research just might be in Omaha, Nebraska, between a Panda Express and a Mattress Firm. A big draw is speed: Nordquist says he can open a trial in as little as two weeks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback